Archives
FDA Approves Durata Drug to Treat Acute Skin Infections
The Food and Drug Administration announced Friday announced that it has approved Durata Therapeutics' drug Dalvance (dalbavancin) that treats skin infections.
Latest Research Articles
NASA's WISE Takes a Bite Out of the Black Hole 'Doughnut' Theory
Lawsuit Warns Politicians That Climate Change Can Cost Them
Human Impact on Amazon Rainforest Grossly Underestimated
Humpback Whales Flock to Boston Harbor in the Hundreds
$1 billion Plan to Make US Particle Physics Hub
Warming Tropical Waters May be Behind Icy US Winter
Specimen Collection Does Not Lead to Species Extinction, Scientists Say
NASA Spitzer Telescope Captures Darkest Cosmic Shadows Ever Seen
New Martian Crater Spotted on Mars (VIDEO)
Xanax Abuse Rising in US; SAMHSA Report
Junk Food Linked to Preterm Birth Risk
Researchers Develop Small Dialysis Machine for Newborns with Kidney Injuries
MOST POPULAR
-
3I/ATLAS Comet Carries Key Molecule For Life From Another Star
-
How Delaying Net Zero Could Trigger 1,000 Years of Extreme Heat and Global Warming
-
10 Fascinating Ways Trees Communicate Underground Through Mycorrhizal Networks
-
Met Office Issues Warning About Thunderstorms And Flooding: Are They Coming To A Place Near You?
-
Are Orcas Friendly to Humans? Killer Whales Mysteriously Attack Boats in Portugal, Even Sinking One
